Non-esterified fatty acids (NEFA) showed a trend towards an elevation in empagliflozin-treated animals and were decreased in all other treatment groups compared to the control group ( Figure 4 a).
← all excerpts
Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY<sub>3-36</sub>, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats.
1
—
—